text: Hicks' research focuses largely on the development and implementation of mass spectrometric methods for protein identification and characterization. Recent work in the Hicks Lab has focused primarily on two areas. The first is the study of post-translational modifications and their role in regulation and development. The second involves a novel analytical pipeline for the discovery and characterization of antimicrobial peptides.
  Hicks research in post-translational modifications typically employs bottom-up proteomics using label-free quantification. Much of this research involves the model organism C. reinhardtii, an important organism in biofuel research due to its tendency to accumulate triacylglycerols. The Hicks Lab has studied the phosphoproteome of C. reinhardtii in order to examine underlying biological processes. Work has also been done to understand cell regulatory pathways, especially the algal analog of the mammalian TOR pathway. To a similar end, Hicks group has extended its work to examine how the reversible oxidation of thiols plays a role in signaling and effector-triggered immunity.
  The increasing threat of antimicrobial resistance has produced a need for novel antimicrobial agents. The Hicks Lab has investigated antimicrobial peptides as a potential source for new antibiotics. Recent work has involved the development of a comprehensive analytical approach using LC-MS for the identification of novel antimicrobial peptides from botanical, fungal, and bacterial sources.